GlassScriptPhysician profile
Paul J Gordon
NPI 1356341994
$5,228.25
in general payments reported to CMS, 2019-2025
13 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,200 · 2020: $106 · 2021: $1,889 · 2022: $131 · 2023: $309 · 2024: $240 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $763 · Travel and Lodging: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $762.60 |
| Travel and Lodging | $139.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,308.57 | 2019-2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,912.25 | 2019-2021 | |
| Medtronic, INC. | $384.53 | 2023-2025 | Signia |
| Baxter Healthcare | $204.67 | 2024-2025 | Perclot |
| Davol INC. | $125.00 | 2025 | Phasix Mesh |
| Covidien LP | $103.50 | 2019 | |
| Conmed Corporation | $38.46 | 2023 | Airseal |
| Galvanize Therapeutics, INC | $35.26 | 2025 | Aliya System |
| Ethicon INC. | $33.05 | 2020 | |
| Medtronic Vascular, INC. | $26.03 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.53 | 2019 | |
| Ethicon US, LLC | $17.83 | 2020 | |
| Endogastric Solutions, INC | $15.57 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.